Opinion|Videos|August 28, 2024
Advancing CML Management Towards an Ideal Patient Journey
The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.
Advertisement
Episodes in this series
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following:
- What are the biggest unmet needs you see for CML patients today, and how do you think emerging therapies and research could address those gaps in the future?
- What excites you most about the potential advancements in CML management that may be on the horizon in the next 5-10 years?
- How do you envision the CML patient experience being transformed compared to today?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Simple Ways for Patients With Cancer to Start Exercising
2
Anemia Management in Myelofibrosis: Survival and Quality of Life
3
Finding Credible Voices in the Lynch Syndrome Community
4
How Does FDA-Approved Blenrep Treat Multiple Myeloma?
5
